Skip to main content
Clinical Trials/CTRI/2023/10/059262
CTRI/2023/10/059262Not yet recruitingPhase 2/3

Effectiveness Of Selected Ayurveda Therapeutic Procedures And Physiotherapy In The Management Of Sarvangavata Roga(Spastic Cerebral Palsy) In Children – A Controlled Clinical Trail

Dr Suneetha.R2 sites in 1 country40 target enrollmentStarted: November 15, 2023Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
2
Primary Endpoint
Reduction in spasticity

Study Overview

Brief Summary

This study is a open label double arm, prospective, controlled clinical trail to evaluate the effectiveness of selected ayurveda therapeutical procedures with physiotherapy in the management of spaticity in cerebral palsy children 0f 2 to 10 years

20 subjects fulfilling inclusion criteria, attending kaumarabhritya outpatient department and in patient department of SDMIAH, Bengaluru will be taken in study group.

20 subjects fulfilling inclusion criteria , attending physiotherapy out patient department of SDM physiotherapy college Dharwad will be controlled group respectively.

for study group - abyanga with rasa taila, parisheka with dasamoola kashaya , basti with rasa taila quantity according to priscribed age, masha godhumdhi upnaha for affected limbs and kati done for 15 days 3 sittings

15 days of gap between each sitting, continue physiotherapy at home as adviced

for control group - paediatric physiotherapist adviced physiotherapy done for 15 days , 3 sittings, 15 days gap in between sitting. continue home phyiotherapy excercises as taught

The primary outcome measures - reduction in spasticity, increase in joint range of motion, improved mile stone will be assessed using modified ashworth scale for spasticity, goniometer for range of motion, ICD - mile stone grading, manual muscle power testing.

The secondary outcome measures - improvement of chewing, reduced drooling, improved quality  of life , improved activity of daily leaving

Study Design

Study Type
Interventional
Allocation
Other
Masking
Open Label

Eligibility Criteria

Ages
2.00 Year(s) to 10.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Children of either gender aged between 2-10years with developmental delay and spasticity or diagnosed cases of spastic cerebral palsy 2.Children whose parents are willing to sign the informed assent 3.Diagnosed case of spastic cerebral palsy with well controlled epilepsy.

Exclusion Criteria

  • 1.Children with uncontrolled seizure disorders 2.Children with severe contractures requiring surgical intervention 3.Children with other form of severe disability like muscular dystrophy, metabolic myopathies, genetic muscular disorders.

Outcomes

Primary Outcomes

Reduction in spasticity

Time Frame: 0 week, 4 weeks, 8 weeks,12 weeks

Improved range of movement

Time Frame: 0 week, 4 weeks, 8 weeks,12 weeks

Imrpoved gross motor function

Time Frame: 0 week, 4 weeks, 8 weeks,12 weeks

cerebral palsy quality of life

Time Frame: 0 week, 4 weeks, 8 weeks,12 weeks

Secondary Outcomes

  • reduction of drooling

Investigators

Sponsor
Dr Suneetha.R
Sponsor Class
Other [self]

Study Sites (2)

Loading locations...

Similar Trials